Core Viewpoint - Growth investors are focused on stocks with above-average financial growth, but identifying such stocks can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Universal Health Services (UHS) is currently recommended as a growth stock by the Zacks Growth Style Score system, which evaluates a company's real growth prospects beyond traditional metrics [2] - UHS has a favorable Growth Score and a top Zacks Rank, indicating strong potential for growth investors [2][11] Group 2: Earnings Growth - Historical EPS growth for UHS is 7.1%, but projected EPS growth is expected to be 17% this year, surpassing the industry average of 15% [5] Group 3: Asset Utilization - UHS has an asset utilization ratio (sales-to-total-assets ratio) of 1.11, indicating that the company generates $1.11 in sales for every dollar in assets, which is higher than the industry average of 0.9 [7] - The company's sales are projected to grow by 8% this year, compared to the industry average of 3.4% [7] Group 4: Earnings Estimate Revisions - There have been upward revisions in current-year earnings estimates for UHS, with the Zacks Consensus Estimate increasing by 0.1% over the past month [9] Group 5: Investment Potential - UHS has earned a Growth Score of B and carries a Zacks Rank 2 due to positive earnings estimate revisions, suggesting it is a solid choice for growth investors [11]

Group 1 - Universal Health Services (UHS) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates which significantly impacts stock prices [1][3] - The Zacks rating system is based on changes in earnings estimates, which are tracked through a consensus measure from sell-side analysts [1][6] - Rising earnings estimates suggest an improvement in the underlying business of Universal Health Services, which could lead to higher stock prices [5][10] Group 2 - For the fiscal year ending December 2025, Universal Health Services is expected to earn $18.99 per share, reflecting a 14.3% increase from the previous year [8] - Over the past three months, the Zacks Consensus Estimate for Universal Health Services has increased by 8.5% [8] - The Zacks Rank system maintains a balanced distribution of ratings, with only the top 20% of stocks receiving a 'Strong Buy' or 'Buy' rating, indicating superior earnings estimate revisions [9][10]